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 ABSTRACT 
 The objectives of this study were to (1) evaluate the 
use of a pressure algometer and an automated rumina-
tion monitoring system to assess changes in pain sen-
sitivity and rumination time in response to endotoxin-
induced clinical mastitis and (2) evaluate the effect of 
the nonsteroidal antiinflammatory drug meloxicam on 
pain sensitivity and rumination time, as well as other 
clinical signs, in dairy cattle with endotoxin-induced 
clinical mastitis. Clinical mastitis was induced in 12 
primiparous and 12 multiparous lactating dairy cows 
by intramammary infusion of 25 μg of Escherichia coli
lipopolysaccharide (LPS) into 1 uninfected quarter. Im-
mediately after, half the cows were injected subcutane-
ously with meloxicam (treated group) and half with the 
same volume of a placebo solution (control group). Pain 
sensitivity was assessed by measuring the difference in 
pressure required to elicit a response on the control 
and challenged quarter using an algometer 3 d before, 
immediately before, and at 3, 6, 12, and 24 h after LPS 
infusion and either meloxicam or placebo injection. Ru-
mination was continuously monitored from 2 d before 
to 3 d after LPS infusion using rumination loggers. Ud-
der edema, body temperature, somatic cell score, and 
dry matter intake were also monitored to evaluate the 
occurrence and the duration of the inflammation after 
LPS infusion. In control animals, the difference in the 
pressure applied to the control and challenged quarters 
(control − challenged quarter) increased by 1.1 ± 0.4 
kg of force 6 h after LPS infusion compared with the 
baseline, suggesting an increase in pain sensitivity in 
the challenged quarter. Neither the LPS infusion nor 
the meloxicam treatment had an effect on daily rumi-
nation time. However, the rumination diurnal pattern 
on the day of LPS infusion showed an overall deviation 
from the baseline pattern. Cows spent less time rumi-
nating in the hours following LPS infusion and more 
time ruminating later in the day. Meloxicam did not 
alter somatic cell score or dry matter intake. However, 
meloxicam-treated animals had less udder edema and 
a lower body temperature in the hours following LPS 
infusion compared with control animals. In conclu-
sion, pressure algometers and rumination loggers show 
promise as tools to detect mastitis and monitor recov-
ery on farm. Further, meloxicam has a beneficial effect 
in relieving pain and decreasing udder edema and body 
temperature in LPS-induced clinical mastitis. 
 Key words:   algometer ,  behavior ,  endotoxin challenge , 
 nonsteroidal antiinflammatory drug 
 INTRODUCTION 
 Mastitis continues to be a prevalent and economically 
detrimental disease in the dairy industry. The negative 
effects of clinical mastitis regarding discomfort, pain, 
and reduced welfare are probably underestimated. In 
a study by Kielland et al. (2010), it was found that on 
a 10-point scale, dairy producers ranked only severe 
cases of mastitis as one of the most painful conditions 
in adult cattle, with a pain assessment score of 7.6, in 
relation to other common health problems. Milder cases 
of mastitis were ranked much lower for the intensity 
of pain, with a pain assessment score of 5.7. However, 
cows can experience pain in even mild cases of masti-
tis and, therefore, welfare is compromised (Leslie and 
Petersson-Wolfe, 2012). 
 Measuring pain associated with mastitis is chal-
lenging. In the past, udder pain has commonly been 
measured with subjective scales (Banting et al., 2008). 
However, new technologies have been recently developed 
for a more objective assessment of pain. One example 
is the pressure algometer, which quantifies the pressure 
that can be exerted on a certain area of the body before 
the animal responds (moves away from the pressure). 
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The maximum pressure applied is interpreted as the 
pain threshold response of the animal. The algometer 
has been used successfully in studies evaluating pain 
associated with dehorning (Heinrich et al., 2010) and 
lameness (Dyer et al., 2007). However, to the authors’ 
knowledge, no previous work has used an algometer to 
specifically quantify udder pain associated with clini-
cal mastitis. Recently, Bertulat et al. (2012) validated 
a dynamometer, which measures firmness by applying 
pressure in the udder. Although this tool could be use-
ful in understanding how cows withstand pressure on 
their mammary quarters in cases of mastitis, it has not 
yet been validated for pain assessment. Other measures 
exist that can help assess discomfort during episodes 
of mastitis, such as decreased DMI, rumination time, 
and milk production (Fogsgaard et al., 2012). Rumina-
tion time can easily be monitored on farm by using 
individual rumination loggers, and shows promise as an 
aid in the early detection of illness (Lindgren, 2009). 
Siivonen et al. (2011) reported a decrease in rumination 
time (monitored by observation) in the hours follow-
ing experimental challenge, suggesting that rumination 
time could be used as an indicator of systemic illness 
in mastitis. However, these researchers only followed 6 
cows for a total of 48 h. More research, with a larger 
sample of animals, continuously monitored before 
and after an experimental mastitis challenge is, thus, 
needed.
Pain management therapy with a nonsteroidal anti-
inflammatory drug (NSAID), such as flunixin meglu-
mine, ketoprofen, or meloxicam, can reduce the clinical 
signs of mastitis (Anderson et al., 1986; Banting et al., 
2008; McDougall et al., 2009). The NSAID meloxicam 
is approved for pain mitigation of mastitis in the Eu-
ropean Union, China, Latin America, Australia, and 
New Zealand. When administered subcutaneously, it 
has a peak drug concentration of 4 h in adult cattle 
and a longer half-life than other commercially avail-
able NSAID (approximately 17.5 h) in adult cattle 
(National Office of Animal Health, 2010), which is 
an advantage for its use on farm. Milne et al. (2003) 
assessed pain by applying mechanical stimuli on the 
hind limbs of cows with endotoxin-induced mastitis and 
found that cows treated with meloxicam after masti-
tis diagnosis returned to their normal pain thresholds 
faster than untreated cows. In addition, researchers 
have reported an improvement in milk yield, reduction 
in SCC, and decrease in culling risk when meloxicam 
has been used to treat cases of clinical mastitis (Friton 
and Banting, 2005; McDougall et al., 2009). Further 
research is needed to determine the analgesic effect of 
meloxicam in mastitis by assessing changes in measures 
of pain sensitivity, and in behavioral indicators of dis-
comfort that can be automatically recorded on farm. 
The first objective of this study was to evaluate the 
use of a pressure algometer and rumination loggers to 
assess changes in pain sensitivity and rumination time 
in response to endotoxin-induced clinical mastitis. To 
accomplish this objective, clinical signs associated with 
mastitis (udder edema, body temperature, SCS, and 
DMI) were monitored to evaluate the occurrence and 
duration of the clinical mastitis episode induced by the 
LPS infusion. The second objective was to evaluate 
the effect of the NSAID meloxicam on pain sensitivity, 
rumination time, and other clinical signs in dairy cattle 
with endotoxin-induced clinical mastitis.
MATERIALS AND METHODS
Animals, Housing, and Management
Twenty-four lactating dairy cows were enrolled in 
this study in August 2010, in groups (n = 4) of 6 cows 
at a time. Only animals with no clinical signs of illness 
and no history of treatment for illness in the last 30 
d were selected. All animals were between 10 and 100 
DIM (mean ± SD = 57 ± 19 DIM). The study group 
was blocked into primiparous (n = 12) and multiparous 
(n = 12, parity range = 2 to 4) groups. All animals 
were housed in a tiestall facility at the Ponsonby Dairy 
Research Centre (Ponsonby, ON, Canada). Cows were 
fed a TMR daily at approximately 0900, 1300, and 
1500 h, and were milked daily at approximately 0530 
and 1600 h. The experiment was approved by the Uni-
versity of Guelph Animal Care Committee (Guelph, 
ON, Canada) before the study commenced (Animal 
Utilization Protocol no. 10R050), and all work with 
animals was done according to the guidelines set by the 
Canadian Council on Animal Care (CCAC, 2009).
Experimental Design
Intramammary Escherichia coli LPS Infusion. 
Each animal was challenged in 1 quarter with an intra-
mammary infusion of 25 μg of purified bacterial Esch-
erichia coli LPS (from E. coli 0111:B4; Sigma-Aldrich 
Co., St. Louis, MO) reconstituted in 10 mL of sterile 
saline solution. Only quarters with an SCC of <200,000 
cells/mL (DeLaval direct cell counter; DeLaval Inter-
national AB, Tumba, Sweden) 3 d before the challenge 
were eligible. Preference was given to the right hind 
quarter if it met the eligibility criteria. If not, the left 
hind quarter (n = 5) or the right front quarter (n = 
1) was evaluated. The infusion was performed follow-
ing morning milking (0700 h) on the challenge day (d 
0), after disinfecting the teat with an iodine-based teat 
disinfectant product. More details of the challenge pro-
cedure are described in Cyples et al. (2012).
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Experimental Treatments. Animals were randomly 
assigned to treatment by use of a random number gen-
erator (Random.org, Dublin, Ireland) within the parity 
blocks. Half the animals received meloxicam (treated 
group; Metacam 20 mg/mL solution; Boehringer In-
gelheim GmbH, Ingelheim am Rhein, Germany) and 
half received an equivalent volume of placebo solution, 
which was the Metacam vehicle with the active meloxi-
cam ingredient removed (control group). The 12 control 
animals were the same as used by Cyples et al. (2012). 
Dosage was calculated based on the average weights 
of 10 primiparous and 10 multiparous cows from the 
herd. At a rate of 0.5 mg/kg (dosing volume = 2.5 
mL/100 kg of BW), primiparous cows received a dosage 
of 15 mL, whereas multiparous cows received a dosage 
of 17 mL. The injections were administered subcutane-
ously immediately after the E. coli LPS infusion. All 
researchers and technicians were blind to meloxicam/
placebo treatment throughout the process of data col-
lection and analysis.
Data Collection
Sampling Scheme. Pain sensitivity, udder edema 
score, and SCC were measured at 6 different times 
throughout the study: 3 d before LPS infusion (imme-
diately after the morning milking), immediately before 
the LPS infusion (0 h), and 3, 6, 12, and 24 h after the 
LPS infusion. Rumination time and body temperature 
were measured continuously and DMI was collected 
once daily, from 2 d before to 3 d after LPS infusion.
Pain Sensitivity. Pain sensitivity was measured 
with a pressure algometer (Force Ten FDX 50; Wagner 
Instruments, Greenwich, CT), equipped with a curved 
pressure pad for easier application on the contour of 
the gland. The algometer measured the pressure in kilo-
grams of force (kgf) that could be applied to a quarter 
(Figure 1). While the cow was standing square on all 4 
legs, even pressure was applied with the algometer per-
pendicularly to the quarter, approximately 25 cm ven-
tral to the udder attachments and 5 cm lateral to the 
median suspensory ligament, until the operator could 
not press any further or the animal had an avoidance 
reaction to the pressure, such as kicking or stepping 
away from the applied pressure. The maximum reading 
at the time of algometer removal indicated the level of 
hyperalgesia of the quarter. Pain sensitivity was mea-
sured in the challenged quarter, to measure primary 
hyperalgesia to the inoculation, and the ipsilateral (con-
trol) quarter, to measure secondary hyperalgesia to the 
inoculation. Pressure was always applied and recorded 
on the control quarter first, followed by the challenged 
quarter. The same operator took all measurements. The 
maximum pressure recorded throughout the experiment 
was 10.5 kgf. The difference between the pressure ap-
plied to the control quarter and the challenged quarter 
(control quarter − challenged quarter) was calculated 
and used as the outcome variable for the analysis of 
pain sensitivity.
Rumination Time. Individual rumination log-
gers (HR-Tag; SCR Engineers Ltd., Netanya, Israel) 
attached to collars were used to monitor rumination 
time. The rumination loggers continuously record the 
duration of rumination in 2-h intervals by capturing 
with a microphone the distinctive sounds produced 
when the animal regurgitates the bolus and ruminates 
(Schirmann et al., 2009). Data were transferred to a 
computer twice daily using a mobile reader (SCR En-
gineers Ltd.).
Edema Score. Edema was assessed on the chal-
lenged and control quarter using a 1-to-5 scale (1 = no 
edema; 5 = very severe edema), as described by Nestor 
et al. (1988).
Body Temperature. Body temperature was mea-
sured at 1-min intervals with a temperature data logger 
(Vemco Minilog 8; Vemco Division of AMIRIX Systems 
Inc., Halifax, NS, Canada). This logger was attached 
to a modified controlled internal drug release device 
(CIDR 1380; Pfizer Animal Health, Madison, NJ) and 
inserted vaginally into the cow, as described in Vickers 
et al. (2010). Data were extracted from the loggers and 
transferred to a computer once they were removed from 
the animals.
SCS. Milk samples were aseptically collected to 
determine SCC from the challenged quarter. Samples 
were taken in accordance with the National Mastitis 
Council protocols (National Mastitis Council, Verona, 
WI), frozen at −20°C, and submitted to the Atlantic 
Veterinary College (Charlottetown, PEI, Canada) for 
analysis. Samples were then thawed, and ran through 
a Fossomatic cell counter (Foss Instruments, Hillerød, 
Denmark) for determination of SCC. The SCC values 
were converted to SCS using the following equation:
SCS = log2(SCC/100,000) + 3.
DMI. Dry matter intake for each individual cow was 
measured daily by subtracting the amount of TMR 
orts (leftover feed measured before the morning TMR 
delivery) from the amount of TMR delivered the previ-
ous day. On d −3, 1, and 4 relative to LPS infusion, 
TMR samples were collected and frozen. At a later 
date, these samples were thawed and dried (60°C for 48 
h) to determine DM content. The 3 DM content values 
estimated per enrollment group were averaged and used 
to calculate DMI.
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Data Analysis
All statistical analyses were performed with SAS 
(version 9.2; SAS Institute Inc., Cary, NC), consider-
ing cow as the experimental unit. Experimental days 
were adjusted to start at 0800 h, as this was the time 
by which all cows were infused with LPS. Rumination 
data were summarized to obtain 1 value per cow and 
day. An exploratory analysis showed no differences 
in the measures of pain sensitivity and SCS on d −3 
and h 0 relative to LPS infusion, and the measures 
of rumination time and DMI collected on d −2 and 
d −1 relative to LPS infusion. Therefore, these mea-
surements were averaged to obtain 1 baseline value per 
cow. Edema scores of the challenged quarter were 1 (no 
edema) before LPS infusion in all cases and, therefore, 
the baseline was not included in the analysis. Data were 
analyzed using mixed models (PROC GLIMMIX) that 
included time as a repeated measure over cow, parity 
(primiparous or multiparous), and treatment as fixed 
effects, and the biologically plausible 2-way interac-
tions. The covariance structure was selected based on 
the smallest Akaike information criterion. Variables 
and interactions were removed from the final model if 
P > 0.05 by manual backward elimination. Dunnett’s 
2-tailed test was used as a post hoc test to evaluate dif-
ferences between baseline and subsequent time periods. 
If the treatment × time interaction was significant at 
P ≤ 0.05, differences between baseline and subsequent 
time periods were evaluated within treatment. Residu-
als were examined to verify normality and homogeneity 
of variances, and to detect possible outliers and influ-
ential points.
Rumination data were summarized by cow, day, and 
2-h intervals to assess diurnal patterns. Similarly, body 
temperature data were summarized by cow, day, and 
hour. An exploratory analysis showed that diurnal pat-
terns on d 2 and 1 were very similar and, therefore, 
data were averaged to create a baseline diurnal pat-
tern for each variable. Deviations from baseline in the 
diurnal pattern were limited to d 0 and, therefore, the 
analysis focused on these 2 time periods. In the case of 
rumination, data were analyzed using a similar mixed 
model to the one described above, but including time 
period (baseline or d 0) and 2-h intervals within period 
as repeated measures over cow. In the case of body 
temperature, the exploratory analysis revealed an inter-
action between treatment, time, and hour. Therefore, 
the analysis was stratified by time and the models in-
cluded hour as a repeated measure over cow, parity, and 
treatment as fixed effects, and the biologically plausible 
2-way interactions. Residuals were examined to verify 
normality and homogeneity of variances, and to detect 
possible outliers and influential points.
Figure 1. Pain sensitivity measured with a Force Ten FDX 50 pressure algometer (Wagner Instruments, Greenwich, CT), equipped with 
a curved pressure pad, applied perpendicularly to the quarter, approximately 25 cm ventral to the udder attachments and 5 cm lateral to the 
median suspensory ligament.
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RESULTS
Pain Sensitivity
When the difference of pressure applied to the con-
trol and challenged quarter was analyzed as a measure 
of pain sensitivity, an interaction was observed between 
treatment and time (P = 0.02; Figure 2). Therefore, 
the baseline period was compared with the subsequent 
time periods within each treatment. Whereas no differ-
ences over time were found in the meloxicam-treated 
cows, the difference in pressure applied to the control 
and challenged quarters of control cows increased at 6 h 
(1.1 ± 0.4 kgf; P = 0.04) after LPS infusion compared 
with the baseline. No effect of parity on pain sensitivity 
was observed (P = 0.53).
Rumination Time
Due to technical problems, rumination data from 2 
cows, 1 of each treatment group, were not available. 
Daily rumination time was not affected by LPS infu-
sion (P = 0.74 for the effect of time relative to LPS 
infusion) or by treatment (P = 0.74), and the interac-
tion between treatment and time was not significant 
(P = 0.84). Overall, multiparous cows spent more time 
ruminating than primiparous cows (553 vs. 413 min/d; 
standard error of the difference = 43; P = 0.004). How-
ever, when diurnal patterns were assessed (Figure 3), 
an interaction between time (expressed as baseline or d 
0) and 2-h interval (P < 0.001) was observed after con-
trolling for parity. The diurnal pattern on d 0 showed 
a deviation from the baseline diurnal pattern such that 
cows spent less time ruminating following LPS infusion 
and more time ruminating later in the day.
Clinical Signs
Edema Score. At the time of enrollment, none of 
the cows presented edema in the quarter selected to be 
challenged, whereas 1 cow presented slight edema in the 
control quarter (score = 2). No major changes occurred 
in the control quarter throughout the study. However, 
the LPS infusion caused some degree of udder edema 
(score ≥2) in the challenged quarter of all animals. 
Edema scores peaked 6 h after LPS infusion (Table 
1). Overall, control cows had higher edema scores than 
meloxicam-treated cows after LPS infusion.
Body Temperature. Two temperature loggers, 1 of 
each treatment group, were lost during the study and, 
therefore, data from these 2 cows were not available. 
When the diurnal patterns of body temperature were 
assessed, a treatment by hour interaction was observed 
on d 0 (P = 0.03; Figure 4). In the hours following 
LPS infusion, body temperature increased faster in con-
trol animals, reaching a higher peak temperature than 
meloxicam-treated animals.
SCS. No treatment effect or treatment by time 
interaction was observed on SCS (Table 1). However, 
an overall time effect was observed, such that SCS in-
creased at 6 (2.1 ± 0.5; P < 0.001), 12 (3.7 ± 0.6; P 
Figure 2. Least squares means (±SEM) difference of the maximum pressure (kilograms of force; kgf) applied to the control and the chal-
lenged quarter (control quarter − challenged quarter) of 24 Holstein dairy cows before (baseline) and after (h 3, 6, 12, and 24) intramammary 
infusion with Escherichia coli LPS and injection with either meloxicam (n = 12; ) or placebo solution (n = 12; □). The baseline was calculated 
by averaging the maximum pressure recorded 3 d before and immediately before the LPS infusion. Cows were milked at approximately 0530 
and 1600 h (downward arrows), and samples scheduled at this time were taken following milking. *P ≤ 0.05 when baseline was compared with 
subsequent time periods within each treatment (Dunnett’s 2-tailed test).
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< 0.001), and 24 h (6.5 ± 0.3; P < 0.001) after LPS 
infusion compared with the baseline values.
DMI. One cow was removed from DMI analysis as 
she was identified as an extreme outlier, with exces-
sively low DMI throughout the study period. This cow 
was diagnosed with a displaced abomasum a few days 
later, which may explain her sudden decrease in DMI. 
Overall, multiparous cows had a higher DMI than pri-
miparous cows (22.1 kg vs. 18.5 kg; standard error of 
the difference = 0.8; P < 0.001). No effect was observed 
of treatment (P = 0.62) or treatment by time interac-
tion (P = 0.33) on DMI. However, an overall decrease 
in DMI of 1.0 ± 0.3 kg (P = 0.004) on d 0 compared 
with baseline was observed.
DISCUSSION
Effects of Endotoxin-Induced Clinical Mastitis  
on Pain Sensitivity and Rumination Time
The LPS infusion resulted in a consistent, moderate-
to-severe case of clinical mastitis of limited duration 
(less than 24 h) in all cows. In the hours following LPS 
infusion, an overall increase was observed in edema 
score, SCS, and body temperature. Clinical signs (ede-
ma scores and body temperature) were the most severe 
6 h after LPS infusion, which is in agreement with 
previous studies that measured local signs of inflamma-
tion in the udder and rectal temperature after similar 
endotoxin challenges (Banting et al., 2000; Siivonen et 
Figure 3. Least squares means (±SEM) rumination time (min/2 h) of 22 Holstein dairy cows before (baseline; ) and on the day () of 
intramammary infusion with Escherichia coli LPS. Experimental days were adjusted to start at 0800 h, by which time all cows had received the 
LPS infusion. Cows were fed at approximately 0900, 1300, and 1500 h (open downward arrows) and milked at approximately 0530 and 1600 h 
(solid downward arrows).
Table 1. Least squares means (±SEM) edema scores and SCS of the challenged quarter of 24 Holstein dairy 
cows before (baseline) and after (h 3, 6, 12, and 24) intramammary infusion with Escherichia coli LPS and 
injection with either meloxicam or placebo solution 
Item
Edema score SCS
Control Meloxicam Control Meloxicam
Time
 Baseline 1 1 2.4 ± 0.6 2.3 ± 0.6
 3 h 2.8 ± 0.2 2.3 ± 0.2 2.8 ± 0.6 2.4 ± 0.6
 6 h 3.5 ± 0.2 2.8 ± 0.2 4.9 ± 0.6 4.0 ± 0.6
 12 h 2.9 ± 0.2 2.6 ± 0.2 7.2 ± 0.7 5.0 ± 0.7
 24 h 2.0 ± 0.2 1.4 ± 0.2 9.0 ± 0.3 8.7 ± 0.3
P-valueparity 0.06 0.54
P-valuetreatment 0.01 0.25
P-valuetime <0.001 <0.001
P-valuetreatment×time 0.56 0.29
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al., 2011; Zimov et al., 2011). Similar to those studies, 
SCS in the current study showed a consistent increase 
starting at 6 h after LPS infusion, such that SCS were 
still higher than baseline at 24 h after LPS infusion.
To the knowledge of the authors, this is the first 
study to evaluate the use of a pressure algometer to as-
sess changes in pain sensitivity of the udder in response 
to endotoxin-induced clinical mastitis. However, algom-
eters have been successfully used to assess pain in lame-
ness (Dyer et al., 2007; Liu et al., 2009; Wu et al., 2011) 
and dehorning (Heinrich et al., 2010) in dairy cattle. 
This study showed an increase in the difference of pres-
sure applied to the control and challenged quarter in 
control animals 6 h after the LPS infusion, suggesting 
an increase in pain sensitivity in the challenged quarter. 
Banting et al. (2008) also detected an increase in pain 
sensitivity at udder palpation in the hours following 
experimental induction of mastitis. These results sug-
gest that the algometer can detect pain at the time 
when the most severe signs of endotoxin mastitis occur.
Cows experienced a decrease in rumination time in 
the hours following the LPS infusion. Siivonen et al. 
(2011) also found a decrease in rumination, assessed by 
visual observation between 4 and 8 h after LPS infu-
sion, compared with the previous day. A decrease in 
rumination has been reported to be indicative of stress 
(Anderson and Muir, 2005; Bristow and Holmes, 2007), 
disease (Collier et al., 1982), and pain (Anderson and 
Muir, 2005). Similarly to cows in the study of Siivonen 
et al. (2011), cows in the current study compensated 
for the decrease in rumination later in the day, such 
that no differences existed in total daily rumination 
time before and after LPS infusion. On the other hand, 
cows experienced a mild decrease in daily DMI on the 
day of the challenge. Zimov et al. (2011) did not find 
any effect of the LPS infusion on DMI, whereas Yeiser 
et al. (2012) found a decrease in DMI 2 d after infusing 
E. coli in the mammary gland. The association between 
DMI and rumination is also unclear. Schirmann et al. 
(2012) found a negative correlation between daily DMI 
and rumination time, although a positive correlation 
between hourly DMI and the rumination occurred 4 h 
later. Unfortunately, we could not monitor DMI contin-
uously to assess when the decrease in DMI happened. 
However, as the decrease in rumination time happened 
2 h after the LPS infusion, we suggest that at least 
part of the decrease in rumination cannot be attrib-
uted merely to a decrease in DMI. Further research is 
needed to clarify the mechanism by which LPS caused 
a decrease in rumination.
Effects of Meloxicam on Pain Sensitivity,  
Rumination Time, and Clinical Signs  
in Endotoxin-Induced Clinical Mastitis
Udder pain sensitivity, as measured by a pressure 
algometer, increased after mastitis induction in control 
animals but not in meloxicam-treated animals. Similar-
ly, Heinrich et al. (2010) found that, following dehorn-
ing, double the amount of pressure could be applied to 
the area of dehorning in calves that received meloxicam 
compared with the calves that received a placebo so-
Figure 4. Least squares means (±SEM) body temperature (°C) of 24 Holstein dairy cows on the day of (d 0) intramammary infusion with 
Escherichia coli LPS and injection with either meloxicam (n = 12; ) or placebo solution (n = 12; □). The experimental day was adjusted to 
start at 0800 h, by which time all cows had received the LPS infusion. Cows were fed at approximately 0900, 1300, and 1500 h (open downward 
arrows) and milked at approximately 0530 and 1600 h (solid downward arrows).
2854 FITZPATRICK ET AL.
Journal of Dairy Science Vol. 96 No. 5, 2013
lution. In other studies, the effect of meloxicam after 
experimental induction of mastitis was evaluated using 
different methods to score pain. Banting et al. (2000) 
found a more rapid decrease in pain sensitivity score 
(assessed by local palpation of the udder) following 
endotoxin infusion in the animals that received meloxi-
cam intravenously 4 h after the endotoxin infusion 
compared with the control animals. In addition, Milne 
et al. (2003) found, when assessing pain applying me-
chanical stimuli to the hind limbs, that animals treated 
with meloxicam intravenously on the day of endotoxin 
challenge (at the time of diagnosis) returned to their 
normal pain threshold faster than their untreated coun-
terparts. These findings suggest that meloxicam can 
alleviate the udder pain experienced after endotoxin 
infusion. Meloxicam may attenuate udder hyperalgesia 
because of several changes associated with inhibition 
of cyclooxygenase (COX)-2: reduced localized inflam-
matory mediators, reduced sensitization of peripheral 
afferent nociceptors, and central effects at the level of 
the spinal cord (Vane et al., 1998). Other studies have 
found similar results using other NSAID. Banting et 
al. (2008) found that animals treated with ketoprofen, 
either orally or intramuscularly 2 h after the endotoxin 
infusion, experienced a peak in pain sensitivity at ud-
der palpation 4 h after the endotoxin infusion, and this 
peak decreased rapidly. Control animals had a peak 
in pain sensitivity at 6 h after the endotoxin infusion, 
which decreased more gradually than in the case of 
ketoprofen-treated animals. Similarly, Lohuis et al. 
(1991) found that animals treated with carprofen intra-
venously 2 h after the endotoxin infusion had decreased 
swelling and pain at udder palpation, approximately 5 
to 13 h after carprofen injection, compared with their 
control counterparts.
Meloxicam did not affect daily rumination time, as 
measured by rumination collars. This result is in dis-
agreement with Banting et al. (2000), who reported 
an increase in rumen contractions (assessed by visual 
observation) when administering meloxicam intrave-
nously 4 h after endotoxin infusion. Other studies also 
found a short-term beneficial effect of other NSAID 
on rumination after experimentally inducing mastitis, 
including flunixin meglumine (Lohuis et al., 1989; Wag-
ner and Apley, 2004), flurbiprofen (Lohuis et al., 1989), 
carprofen (Vangroenweghe et al., 2005), and ketoprofen 
(Banting et al., 2008). This discrepancy with previous 
studies was unexpected, as the method of monitoring 
rumen activity in the current study is more objective 
and continuous than the subjective methods used in 
most of the previous studies. Nevertheless, Zimov et 
al. (2011) did not find a significant improvement in 
rumination when flunixin meglumine was administered 
intravenously 4 h after endotoxin infusion. Further re-
search is needed with naturally occurring cases of E. 
coli mastitis, where signs of mastitis are likely pres-
ent for longer and the effect of meloxicam could be 
more easily assessed. The rumination loggers used in 
the current study can monitor rumination continuously 
for longer periods of time in a large number of cows 
and, therefore, are a promising tool to use in large-scale 
studies on farm.
Overall, meloxicam-treated cows had a lower edema 
score (i.e., less local inflammation) than control cows 
in the 24 h following LPS infusion and treatment. This 
is in agreement with Friton et al. (2002), who found a 
decrease in edema 2 d after endotoxin infusion in ani-
mals treated intravenously with meloxicam compared 
with control animals. Similar effects have been found 
when administering other NSAID after experimental 
induction of mastitis, such as carprofen (Lohuis et al., 
1991) and flunixin meglumine (Anderson et al., 1986).
The body temperature of control animals increased 
more rapidly and peaked higher than that of meloxicam-
treated animals. This result contradicts Banting et al. 
(2000), who measured rectal temperature at 2-h inter-
vals and did not find any beneficial effect of meloxicam. 
Differences between studies could be partly due to dif-
ferences in the temperature-recording methods (vaginal 
vs. rectal sampling and 1-min vs. 2-h intervals). Never-
theless, the antipyretic properties of meloxicam are not 
well understood. Whereas other NSAID are known for 
their antipyretic properties, such as the COX-1 prefer-
entially inhibiting the drugs ketoprofen and carprofen, 
meloxicam preferentially inhibits COX-2 enzymes at 
the inflammation site; therefore, its COX-1 activity is 
limited (Lees et al., 2004). Future research is needed to 
explore the beneficial short-term effects of meloxicam 
on body temperature in clinical episodes of mastitis.
The SCS did not decrease after treatment with 
meloxicam, in agreement with other studies that treat-
ed cows intravenously with flunixin meglumine (Ander-
son and Hunt, 1989; Zimov et al., 2011) and carprofen 
(Vangroenweghe et al., 2005) after endotoxin infusion. 
Similarly, Yeiser et al. (2012) did not find an effect of 
flunixin meglumine on SCC, even though mastitis was 
induced by infusing E. coli rather than the endotoxin. 
However, McDougall et al. (2009) reported a decrease 
in SCS when treating naturally occurring mastitis 
with meloxicam, suggesting that some of the effects of 
NSAID might be difficult to assess in experimentally 
induced mastitis.
Meloxicam did not reverse the decrease in DMI ob-
served after inducing mastitis. This lack of effect of 
meloxicam is in agreement with Zimov et al. (2011), 
who treated cows with flunixin meglumine after experi-
mentally inducing mastitis with LPS. In contrast, Yeiser 
et al. (2012) found that flunixin meglumine injected 
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intravenously after E. coli infusion counteracted the 
decrease in DMI that nontreated animals experienced 1 
d after the infusion. However, this effect was limited in 
time, as treated animals showed a decrease in DMI 2 d 
after the challenge.
CONCLUSIONS
Udder pain sensitivity, as measured by a pressure 
algometer, increased after mastitis induction in control 
animals but not in meloxicam-treated animals. Overall, 
rumination time was reduced in the hours following 
infusion. Thus, pressure algometers and rumination 
loggers show promise as tools to monitor mastitis. 
Meloxicam had a beneficial effect in relieving udder 
pain in the hours following LPS infusion and reducing 
udder edema and body temperature, although it did 
not alter rumination time, DMI, or SCS.
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